44 studies found for:    Open Studies | "Hypertriglyceridemia"
Show Display Options
Rank Status Study
1 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
2 Recruiting Hypertriglyceridaemia - Cause and Effects
Condition: Hypertriglyceridaemia
3 Unknown  Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
Conditions: Hypertension;   Hypertriglyceridemia
Interventions: Dietary Supplement: DHA-EPA;   Drug: Ciprofibrate
4 Recruiting The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: volanesorsen;   Drug: Placebo
5 Recruiting Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia
Conditions: Hyperferritinemia;   Hypertriglyceridemia
Interventions: Procedure: Phlebotomy;   Behavioral: Dietary and lifestyle counseling.
6 Unknown  Triglyceride Lowering Study
Condition: Hypertriglyceridemia
Intervention: Drug: Omega-3-Acid Ethyl Esters
7 Unknown  Omega-3 Fatty Acid Supplementation in Children
Conditions: Chronic Kidney Disease;   Hypertriglyceridemia
Interventions: Dietary Supplement: n-3 Fatty Acid supplement;   Dietary Supplement: Placebo
8 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
9 Unknown  Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: 290 mg DCCR;   Drug: 435 mg DCCR;   Drug: 135 mg fenofibric acid;   Drug: Placebo;   Drug: atorvastatin
10 Recruiting Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Condition: Hypertriglyceridemia
Interventions: Drug: ARI-3037MO;   Drug: Placebo
11 Recruiting AZD0585 Phase III Long-term Study in Japan
Condition: Hypertriglyceridemia,
Interventions: Drug: AZD0585;   Drug: AZD0585 placebo
12 Not yet recruiting The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
Condition: Severe Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: SC401B 2 capsules;   Drug: SC401B 4 capsules;   Drug: SC401B 6 capsules
13 Unknown  Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Conditions: Insulin Resistance;   Hypertriglyceridemia
Interventions: Drug: Rosiglitazone;   Drug: Fenofibrate;   Behavioral: Weight Loss
14 Recruiting PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Hypertriglyceridemia
Interventions: Drug: Metformin Eicosapentaenoate;   Drug: Metformin HCl and Vascepa
15 Unknown  Bioavailability of EPA and DHA From Two Dietary Supplements
Condition: Hypertriglyceridemia
Intervention: Dietary Supplement: DHA-rich fish oil versus Phospholipid-rich fish oil
16 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
17 Unknown  Effects of DPP-4 Inhibition on Triglycerides
Conditions: Type 2 Diabetes;   Hypertriglyceridemia
Intervention: Drug: Saxagliptin
18 Unknown  Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
19 Recruiting Maternal Hypertriglyceridaemia Study
Condition: Metabolic Syndrome X
Intervention: Procedure: Blood sampling
20 Recruiting A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD;   Hypertriglyceridemia
Interventions: Drug: Placebo;   Drug: Omega-3 carboxylic acid;   Drug: Fenofibrate 200mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years